ALLY Adaptive Cataract Treatment System

ALLY Adaptive Cataract Treatment System is an FDA 510(k)-cleared medical device (K220259) manufactured by Lensar, Inc.. This device is classified under the Ophthalmic specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on June 8, 2022. Regulation: 8.